---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-26-000577"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2026-03-31T23:59:59+00:00"
generated_at: "2026-05-15T08:07:45.076246+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Lipella Pharmaceuticals files Chapter 11 bankruptcy, plans 363 sale process

## Summary
- Filed voluntary Chapter 11 petition in Western District of Pennsylvania on March 30, 2026.
- Company intends to pursue a 363 sale process to maximize value for creditors.
- Seeks customary first-day relief to continue operations, including payroll and cash management.
- Company cautions trading in common stock is highly speculative and may not reflect recovery for holders.

## SEC filing metadata
- accession: 0001753926-26-000577
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2026-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- confidence: high
- sec_items: 1.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392626000577/0001753926-26-000577-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392626000577/g085465_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-26-000577
- JSON: https://secwatch.observer/filing/0001753926-26-000577.json
- Plain text: https://secwatch.observer/filing/0001753926-26-000577.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.